Moreover, it has been shown that when tau interacts with the plasma membrane, the propensity for fibrillization increases, and within the context of AD, variability in soluble tau has been shown to occur in the presence of Aβ pathology but before significant NFT pathology [22–31]. Here, MAPT is linked to Alzheimer disease.